Capital Analysts »

Verrica Pharmaceuticals shares owned by Capital Analysts

Quarter-by-quarter ownership of Verrica Pharmaceuticals (VRCA) shares owned by Capital Analysts from 13F filings

Historical chart of Capital Analysts investment in Verrica Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Verrica Pharmaceuticals held by Capital Analysts consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Verrica Pharmaceuticals by Capital Analysts

Quarter filed Position value Share count Share price at filing
2025-09-30 $6.0k 1.5k 4.00

More positions owned by Capital Analysts

Spdr Series Trust Portfolio S&p500 (SPLG)
Ishares Tr Core S&p500 Etf (IVV)
Fidelity Merrimack Str Tr Total Bd Etf (FBND)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Core Msci Emkt (IEMG)
J P Morgan Exchange Traded F Core Plus Bd Etf (JCPB)
Flexshares Tr Iboxx 5yr Trgt (TDTF)
Fidelity Covington Trust Enhanced Mid (FMDE)
Microsoft Corporation (MSFT)
Spdr Series Trust Portfolio Intrmd (SPIB)
Spdr Series Trust Portfli High Yld (SPHY)
Franklin Templeton Etf Tr Intl Cor Div Til (DIVI)
Apple (AAPL)
Ishares Tr Core S&p Ttl Stk (ITOT)
Vanguard Bd Index Fds Short Trm Bond (BSV)

View all positions for Capital Analysts

Top funds holding Verrica Pharmaceuticals

Caligan Partners
Armistice Capital
Boothbay Fund Management
Vanguard Group
Sovran Advisors
Millennium Management
Geode Capital Management
UBS Group
Renaissance Technologies
Mariner Wealth Advisors
State Street Corporation
Northern Trust
Bridgeway Capital Management
BlackRock
FMR

View all funds holding Verrica Pharmaceuticals